STAR — Strides Pharma Science Share News
0.000.00%
Last trade - 00:00- IN₹93.54bn
- IN₹107.43bn
- IN₹48.59bn
Brief: Strides Pharma Science Says Receipt Of NCLT Approval For Creation Of Onesource
Brief: Strides Pharma Science Unit Buys Remaining Stake In Strides Switzerland For CHF 1.01 Mln
India's Strides Pharma gains on posting Q2 profit
Brief: Strides Pharma Science Says Onesource Gets Equity Commitments Of 8.01 Bln Rupees
Brief: Strides Pharma Science Says RBI Levied Compounding Amount Of 15.1 Million Rupees On Co
Brief: Strides Pharma Science Gets USFDA Approval For Fluoxetine Tabs 60 Mg
Brief: Strides Pharma Science Says Got Approval From Shareholders, Secured Creditors For Creation Of Onesource
India's Strides Pharma rises on US FDA nod for drug to treat asthma, lung diseases
Brief: Strides Pharma Science Gets USFDA Approval For Theophylline Extended-Release Tablet
India's Strides Pharma hits over 7-yr high on Q1 profit
Brief: Strides Pharma Science June-Quarter Consol Net Profit 702 Mln Rupees
India's Strides Pharma jumps after reporting Q4 profit
Brief: Strides Pharma Science Aiming For Net Debt Reduction Of 5 Billion Rupees In Fy25
Brief: Strides Pharma Science Posts March-Qtr Consol Net Profit
Brief: Strides Pharma Science Receives USFDA Approval For Sucralfate Oral Suspension, 1Gm/10Ml
India's Strides Pharma up after US FDA nod for kidney disease drug
Brief: Strides Pharma Science Says Unit Receives USFDA Approval For Sevelamer Carbonate Tablets, 800 Mg
Brief: Strides Pharma Science Says Unit Receives USFDA Approval For Fluoxetine Tabs
Brief: Strides Pharma Science Proposes To Consolidate Group's South African Business Under Trinity Pharma (Proprietary), South Africa